Hemostats Market Size 2025-2029
The hemostats market size is forecast to increase by USD 910.9 million, at a CAGR of 5.8% between 2024 and 2029.
The growing volume of surgical procedures is a primary market driver for the global hemostats market. Post-surgical adhesion formation is a significant complication, increasing the demand for effective adhesion barrier products and advanced wound closure methods. In response, the hemostats and tissue sealants market has seen innovation in products that reduce the need for blood transfusion reduction. The expansion of healthcare infrastructure, with a rise in hospitals and surgical centers, further supports this demand, creating more settings where bleeding control management is essential. However, the effective use of these advanced products is constrained by a dearth of skilled medical personnel, which impacts the adoption of sophisticated artery closure techniques.Technological advancements in surgical procedures necessitate continuous training for healthcare professionals. This addresses the challenge of ensuring proper application of products designed for hemostasis in surgical procedures. The market is also seeing developments in related fields, such as hemoglobin testing and hematology analyzers, which contribute to better overall patient blood management. As new surgical sealants and hemostatic powder options become available, the focus remains on improving patient recovery improvement and reducing operating time. The development of a robust hemostasis diagnostics market complements these advancements, ensuring that clinicians can make informed decisions about intraoperative bleeding management and the use of a flowable hemostatic matrix.
What will be the Size of the Hemostats Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The market is characterized by ongoing innovation in materials science, with a focus on developing advanced solutions for surgical bleeding control. The evolution from traditional oxidized regenerated cellulose and absorbable gelatin sponge to synthetic hemostatic agents and plant-based polysaccharide hemostats reflects a move toward enhanced safety and biocompatibility testing. In the field of hemostasis diagnostics market, these developments are crucial. The performance of a flowable hemostatic matrix in achieving effective wound surface coverage during cardiothoracic procedures is a key area of clinical evaluation, influencing product adoption and clinical preference drivers.Application-specific advancements are shaping product development, particularly for minimally invasive techniques and robotic-assisted surgery. Products must be adaptable for use in complex neurosurgical applications and deep lesion treatment, where precision is paramount. The efficacy of hemostatic powder and other flowable hemostatic agents in managing diffuse bleeding management is critical. The broader prosthetics and femoral prostheses market also benefits from improved bleeding control during implantation surgeries. This focus on specialized applications is driving the creation of user-friendly surgical tools that integrate seamlessly into modern surgical workflows and support tissue regeneration support.
How is this Hemostats Industry segmented?
The hemostats industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Formulation
- Matrix and gels
- Sheet and pad
- Sponge
- Powder
- Product type
- Thrombin-based hemostats
- Gelatin-based hemostats
- Collagen-based hemostats
- End-user
- Hospitals
- ASCs
- Specialty clinics
- Geography
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
By Formulation Insights
The matrix and gels segment is estimated to witness significant growth during the forecast period.
The matrix and gels segment holds a dominant position, driven by the significant clinical advantages these formulations offer. Their flowable nature allows for easy application and complete coverage of irregularly shaped wound surfaces, which is particularly beneficial for deep lesion treatment and managing diffuse bleeding that is difficult to address with conventional methods. Products in this category are valued for their high hemostatic efficacy and strong biocompatibility testing profiles.
These hemostatic agents, often composed of a flowable gelatin matrix combined with active components, are preferred in a variety of surgical disciplines for their reliability. In 2023, this segment accounted for over 40% of the market, reflecting its widespread adoption. The ability of these products to facilitate rapid temporary blood clot formation while being fully resorbable contributes to their status as a cornerstone of modern surgical bleeding control and effective blood loss management.
Request Free Sample
The Matrix and gels segment was valued at USD 966.20 million in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 39.3% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
In 2024, North America commands the largest share of the market, a position it is expected to maintain throughout the forecast period. This leadership is underpinned by the region's highly advanced healthcare infrastructure, significant R&D investment, and a high adoption rate of innovative medical products for surgical bleeding control. The presence of a large geriatric population and a high volume of surgical procedures, including orthopedic reconstructions and cardiothoracic procedures, provides a sustained demand for effective hemostatic agents.
The region's growth is further supported by a favorable reimbursement environment for advanced surgical devices and a well-established regulatory framework that ensures product safety and efficacy. North America is projected to contribute 39.3% of the market's incremental growth, with the United States being the primary contributor. The ongoing need for solutions that improve patient recovery improvement and reduce complications like post-surgical adhesion formation continues to drive innovation and market expansion in the region.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global hemostats market is witnessing significant growth, driven by the increasing volume of surgical procedures and the critical need for effective blood loss management during surgery. Innovations range from the traditional absorbable gelatin sponge for surgical use and oxidized regenerated cellulose in wound closure to more advanced options. These include a flowable hemostatic matrix for complex bleeding and specialized thrombin-based agents in cardiovascular surgery. The demand for collagen-based hemostats for orthopedic use and the versatile plant-based polysaccharide for broad surgical settings highlights the trend towards procedure-specific solutions. Furthermore, the rise of hemostatic solutions for robotic-assisted surgery is crucial for managing bleeding in minimally invasive surgery, ultimately reducing blood transfusions with hemostatic agents and improving patient outcomes.Despite market expansion, stakeholders must navigate several challenges. The clinical limitations of hemostatic products and potential immunogenic responses to biologic hemostats require careful consideration. The need for skilled personnel for hemostat product application and the high cost of advanced surgical hemostasis procedures can limit adoption. However, growth opportunities are substantial, particularly for advanced hemostats in emerging healthcare markets. Success hinges on obtaining regulatory approval for novel hemostatic devices, including resorbable sponges for internal surgical use and combination products with carrier scaffolds. The industry is also exploring synthetic raw materials for hemostat manufacturing and developing adhesion barrier products in abdominal surgery to broaden application scope and address unmet clinical needs.
What are the key market drivers leading to the rise in the adoption of Hemostats Industry?
- The increasing number of surgical operations conducted globally is a primary factor driving market expansion.
The increasing global volume of surgical procedures is a fundamental driver for the market. A significant portion of all red blood cell transfusions, estimated at 60% to 70%, occurs during surgical interventions, highlighting the critical need for effective bleeding control. The rising incidence of post-surgical adhesion formation, a serious complication causing significant discomfort and sometimes requiring repeat surgeries, further elevates the demand for adhesion barrier products. As the number of operations for lifestyle-related diseases, orthopedic conditions, and trauma cases grows, so does the reliance on advanced wound closure methods. This creates a sustained demand for products that facilitate temporary blood clot formation and ensure precise artery closure techniques to minimize complications and improve patient outcomes.A rising focus on research and development is another key factor shaping the market. This involves extensive work on developing novel materials and formulations to enhance product efficacy and safety. Significant investment is directed toward creating synthetic hemostatic agents and polysaccharide-based hemostats to reduce the reliance on animal-derived components like bovine thrombin components and porcine gelatin matrix, thereby minimizing the pathogen transmission risk. The development of recombinant thrombin sources and advanced flowable hemostatic agents is a direct result of these research efforts. Innovation also centers on creating combination hemostatic products that offer multiple mechanisms of action for more effective surgical bleeding control in complex scenarios.
What are the market trends shaping the Hemostats Industry?
- The expansion of healthcare infrastructure, marked by a growing number of hospitals and surgical centers, is a key upcoming market trend.
A noticeable trend is the rise in the number of hospitals and surgical centers, particularly in developing economies. This expansion of healthcare infrastructure directly translates to a larger customer base for surgical devices, including those used for surgical bleeding control and intraoperative bleeding management. As new facilities are built and existing ones are upgraded, there is a parallel increase in the volume of surgical interventions performed. This trend is creating substantial opportunities for providers of both mechanical hemostatic agents and active hemostatic agents. The demand is not just for basic supplies but also for advanced wound closure technologies that can improve efficiency and patient outcomes within these new and expanding clinical settings, including in the broader hemostats and tissue sealants market.A growing focus on effective blood loss management in patients during surgeries is shaping clinical practice and product demand. This emphasis is driven by a desire to improve patient safety, reduce the need for blood transfusions, and shorten patient recovery improvement times. Clinicians are increasingly adopting advanced hemostatic solutions that offer rapid and reliable bleeding control, moving beyond traditional methods. This trend supports the adoption of premium products like flowable hemostatic agents and combination hemostatic products, which are designed for complex bleeding scenarios. The shift towards value-based healthcare, where outcomes are prioritized, further reinforces this focus, making effective coagulation cascade activation and blood transfusion reduction key performance indicators in surgical care, which is also a key area of focus in the hemostasis diagnostics market.
What challenges does the Hemostats Industry face during its growth?
- A significant challenge impacting industry growth is the shortage of trained medical professionals proficient in the effective application of hemostat products.
A significant challenge is the dearth of medical personnel skilled in the effective use of hemostatic products. Advanced devices require specific handling and application techniques to prevent complications like continued bleeding or ischemia. A projected shortfall of 21% in cardiac surgeons in some developed nations exemplifies this wider issue. The rapid evolution of the technological landscape means that continuous training is necessary for physicians to properly use sophisticated products for wound closure methods and artery closure techniques. The scarcity of experienced surgeons in both developed and emerging economies is a major factor restricting the broader adoption of advanced hemostatic agents, as practitioners may hesitate to use unfamiliar technologies.The high cost of surgical procedures presents another notable challenge. As healthcare systems globally face pressure to contain expenses, the budget allocated for surgical supplies comes under scrutiny. While advanced hemostatic agents offer clinical benefits such as operating time reduction and fewer complications, their higher price point can be a barrier to adoption, particularly in facilities with tight financial constraints. This dynamic forces purchasing decisions to balance clinical efficacy with cost-effectiveness analysis. The high cost of the overall surgery can lead to pressure on procuring less expensive hemostatic options, even if premium products might offer better long-term value by reducing postoperative bleeding rates.
Exclusive Customer Landscape
The hemostats market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the hemostats market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, hemostats market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Aegis Lifesciences Pvt. Ltd. - The product portfolio features advanced hemostatic solutions designed to address various bleeding situations in surgical settings. Offerings include absorbable powder formulations packaged in kits for convenient application. These products provide clinicians with effective and reliable tools for controlling hemorrhage during procedures, aligning with the growing demand for efficient bleeding management solutions that support positive surgical outcomes.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Aegis Lifesciences Pvt. Ltd.
- Artivion Inc.
- Axio Biosolutions Pvt. Ltd.
- B.Braun SE
- Baxter International Inc.
- Becton Dickinson and Co.
- CuraMedical BV
- Gelita AG
- Grayline Medical Inc.
- Integra LifeSciences Corp.
- Johnson and Johnson Services Inc.
- MBP Medical Biomaterial Products GmbH
- Pfizer Inc.
- STERIS plc
- Ted Pella Inc.
- Teleflex Inc.
- Towne Brothers Pvt. Ltd.
- World Precision Instruments
- Ydm Corp.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Hemostats Market
In May 2024, Artivion Inc. announced that it received US Food and Drug Administration (FDA) approval for an expanded indication for its PerClot Absorbable Hemostatic System to include cardiothoracic surgical procedures.In March 2024, Baxter International Inc. highlighted new data and its surgical care portfolio, including the FLOSEAL Hemostatic Matrix, at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) annual meeting.In February 2024, Johnson and Johnson Services Inc. presented new clinical data at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting, reinforcing the utility of its medical technology portfolio, which includes products for surgical wound closure.
Research Analyst Overview
The global hemostats market continues to evolve, driven by the need for effective blood loss management in complex medical settings. The application of various agents, including biologic hemostatic agents and mechanical hemostatic agents, is fundamental to achieving hemostasis in surgical procedures. Products such as an absorbable gelatin sponge, oxidized regenerated cellulose, and resorbable collagen-based sponges facilitate temporary blood clot formation through different mechanisms. The development of thrombin-based hemostatic agents and collagen-based hemostatic agents signifies a shift towards more targeted coagulation cascade activation. Alongside these, fibrin sealant and other active hemostatic agents represent ongoing refinements in wound closure methods. The sector's expansion reflects these advancements, with industry projections indicating an approximate 6% yearly increase in market valuation, underscoring the dynamic nature of bleeding control management technologies.Further diversification is evident through specialized products for clinical needs like advanced wound closure and artery closure techniques. The introduction of flowable hemostatic agents, such as a flowable hemostatic matrix using a porcine gelatin matrix, has enhanced tissue anchoring and application precision. Innovations including a plant-based polysaccharide hemostat and other polysaccharide-based hemostats offer alternatives. The use of hemostatic powder and microfibrillar collagen provides different modalities for endoscopic hemostasis. Concurrently, surgical sealants and adhesion barrier products address post-surgical adhesion formation. The evolution of a complete absorbable hemostatic system, integrating elements like bovine thrombin components and synthetic hemostatic agents, is shaped by stringent medical device regulation that governs combination hemostatic products and gelatin-based hemostatic agents like the flowable gelatin matrix.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Hemostats Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
291
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 5.8%
|
|
Market growth 2024-2029
|
USD 910.9 million
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
5.4%
|
|
Key countries
|
US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, India, Japan, South Korea, Indonesia, Thailand, Brazil, Saudi Arabia, UAE, Turkey, Argentina, Colombia, South Africa, Israel
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Hemostats Market Research and Growth Report?
- CAGR of the Hemostats industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the hemostats market growth of industry companies
We can help! Our analysts can customize this hemostats market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Formulation
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global Hemostats Market 2019 - 2023
- Historic Market Size - Data Table on Global Hemostats Market 2019 - 2023 ($ billion)
- 5.2 Formulation segment analysis 2019 - 2023
- Historic Market Size - Formulation Segment 2019 - 2023 ($ billion)
- 5.3 Product Type segment analysis 2019 - 2023
- Historic Market Size - Product Type Segment 2019 - 2023 ($ billion)
- 5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6 Qualitative Analysis
- 6.1 The AI impact on Global Hemostats Market
7 Five Forces Analysis
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Formulation
- 8 Market Segmentation by Formulation
- 8.1 Market segments
- Chart on Formulation - Market share 2024-2029 (%)
- Data Table on Formulation - Market share 2024-2029 (%)
- 8.2 Comparison by Formulation
- Chart on Comparison by Formulation
- Data Table on Comparison by Formulation
- 8.3 Matrix and gels - Market size and forecast 2024-2029
- Chart on Matrix and gels - Market size and forecast 2024-2029 ($ billion)
- Data Table on Matrix and gels - Market size and forecast 2024-2029 ($ billion)
- Chart on Matrix and gels - Year-over-year growth 2024-2029 (%)
- Data Table on Matrix and gels - Year-over-year growth 2024-2029 (%)
- 8.4 Sheet and pad - Market size and forecast 2024-2029
- Chart on Sheet and pad - Market size and forecast 2024-2029 ($ billion)
- Data Table on Sheet and pad - Market size and forecast 2024-2029 ($ billion)
- Chart on Sheet and pad - Year-over-year growth 2024-2029 (%)
- Data Table on Sheet and pad - Year-over-year growth 2024-2029 (%)
- 8.5 Sponge - Market size and forecast 2024-2029
- Chart on Sponge - Market size and forecast 2024-2029 ($ billion)
- Data Table on Sponge - Market size and forecast 2024-2029 ($ billion)
- Chart on Sponge - Year-over-year growth 2024-2029 (%)
- Data Table on Sponge - Year-over-year growth 2024-2029 (%)
- 8.6 Powder - Market size and forecast 2024-2029
- Chart on Powder - Market size and forecast 2024-2029 ($ billion)
- Data Table on Powder - Market size and forecast 2024-2029 ($ billion)
- Chart on Powder - Year-over-year growth 2024-2029 (%)
- Data Table on Powder - Year-over-year growth 2024-2029 (%)
- 8.7 Market opportunity by Formulation
- Market opportunity by Formulation ($ billion)
- Data Table on Market opportunity by Formulation ($ billion)
9 Market Segmentation by Product Type
- 9 Market Segmentation by Product Type
- 9.1 Market segments
- Chart on Product Type - Market share 2024-2029 (%)
- Data Table on Product Type - Market share 2024-2029 (%)
- 9.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
- 9.3 Thrombin-based hemostats - Market size and forecast 2024-2029
- Chart on Thrombin-based hemostats - Market size and forecast 2024-2029 ($ billion)
- Data Table on Thrombin-based hemostats - Market size and forecast 2024-2029 ($ billion)
- Chart on Thrombin-based hemostats - Year-over-year growth 2024-2029 (%)
- Data Table on Thrombin-based hemostats - Year-over-year growth 2024-2029 (%)
- 9.4 Gelatin-based hemostats - Market size and forecast 2024-2029
- Chart on Gelatin-based hemostats - Market size and forecast 2024-2029 ($ billion)
- Data Table on Gelatin-based hemostats - Market size and forecast 2024-2029 ($ billion)
- Chart on Gelatin-based hemostats - Year-over-year growth 2024-2029 (%)
- Data Table on Gelatin-based hemostats - Year-over-year growth 2024-2029 (%)
- 9.5 Collagen-based hemostats - Market size and forecast 2024-2029
- Chart on Collagen-based hemostats - Market size and forecast 2024-2029 ($ billion)
- Data Table on Collagen-based hemostats - Market size and forecast 2024-2029 ($ billion)
- Chart on Collagen-based hemostats - Year-over-year growth 2024-2029 (%)
- Data Table on Collagen-based hemostats - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by Product Type
- Market opportunity by Product Type ($ billion)
- Data Table on Market opportunity by Product Type ($ billion)
10 Market Segmentation by End-user
- 10 Market Segmentation by End-user
- 10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 10.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ billion)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- 10.4 ASCs - Market size and forecast 2024-2029
- Chart on ASCs - Market size and forecast 2024-2029 ($ billion)
- Data Table on ASCs - Market size and forecast 2024-2029 ($ billion)
- Chart on ASCs - Year-over-year growth 2024-2029 (%)
- Data Table on ASCs - Year-over-year growth 2024-2029 (%)
- 10.5 Specialty clinics - Market size and forecast 2024-2029
- Chart on Specialty clinics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Specialty clinics - Market size and forecast 2024-2029 ($ billion)
- Chart on Specialty clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Specialty clinics - Year-over-year growth 2024-2029 (%)
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
11 Customer Landscape
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.3.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.4.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.4.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.4.4 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.4.5 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 12.4.6 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.5.1 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.5.2 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.5.3 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.5.4 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.5.5 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 12.5.6 Thailand - Market size and forecast 2024-2029
- Chart on Thailand - Market size and forecast 2024-2029 ($ billion)
- Data Table on Thailand - Market size and forecast 2024-2029 ($ billion)
- Chart on Thailand - Year-over-year growth 2024-2029 (%)
- Data Table on Thailand - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.6.2 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 12.6.3 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.6.4 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 12.6.5 Argentina - Market size and forecast 2024-2029
- Chart on Argentina - Market size and forecast 2024-2029 ($ billion)
- Data Table on Argentina - Market size and forecast 2024-2029 ($ billion)
- Chart on Argentina - Year-over-year growth 2024-2029 (%)
- Data Table on Argentina - Year-over-year growth 2024-2029 (%)
- 12.6.6 Colombia - Market size and forecast 2024-2029
- Chart on Colombia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Colombia - Market size and forecast 2024-2029 ($ billion)
- Chart on Colombia - Year-over-year growth 2024-2029 (%)
- Data Table on Colombia - Year-over-year growth 2024-2029 (%)
- 12.6.7 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 12.6.8 Israel - Market size and forecast 2024-2029
- Chart on Israel - Market size and forecast 2024-2029 ($ billion)
- Data Table on Israel - Market size and forecast 2024-2029 ($ billion)
- Chart on Israel - Year-over-year growth 2024-2029 (%)
- Data Table on Israel - Year-over-year growth 2024-2029 (%)
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
- 13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Growing volume of surgical procedures performed
- Rising focus on research and development
- Increasing incidence of sports-related injuries and spinal ailments
- 13.2 Market challenges
- Dearth of medical personnel skilled in effective use of hemostat products
- High cost of surgical procedures
- Clinical and other limitations associated with hemostat products
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Rise in number of hospitals and surgical centers
- Rising focus on effective blood loss management in patients during surgeries
- Growing adoption of advanced hemostats in emerging markets
14 Competitive Landscape
- 14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Aegis Lifesciences Pvt. Ltd.
- Aegis Lifesciences Pvt. Ltd. - Overview
- Aegis Lifesciences Pvt. Ltd. - Product / Service
- Aegis Lifesciences Pvt. Ltd. - Key offerings
- SWOT
- 15.5 Artivion Inc.
- Artivion Inc. - Overview
- Artivion Inc. - Business segments
- Artivion Inc. - Key offerings
- Artivion Inc. - Segment focus
- SWOT
- 15.6 Axio Biosolutions Pvt. Ltd.
- Axio Biosolutions Pvt. Ltd. - Overview
- Axio Biosolutions Pvt. Ltd. - Product / Service
- Axio Biosolutions Pvt. Ltd. - Key offerings
- SWOT
- 15.7 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key news
- B.Braun SE - Key offerings
- SWOT
- 15.8 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
- 15.9 Becton Dickinson and Co.
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key news
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Segment focus
- SWOT
- 15.10 CuraMedical BV
- CuraMedical BV - Overview
- CuraMedical BV - Product / Service
- CuraMedical BV - Key offerings
- SWOT
- 15.11 Grayline Medical Inc.
- Grayline Medical Inc. - Overview
- Grayline Medical Inc. - Product / Service
- Grayline Medical Inc. - Key offerings
- SWOT
- 15.12 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
- 15.13 MBP Medical Biomaterial Products GmbH
- MBP Medical Biomaterial Products GmbH - Overview
- MBP Medical Biomaterial Products GmbH - Product / Service
- MBP Medical Biomaterial Products GmbH - Key offerings
- SWOT
- 15.14 STERIS plc
- STERIS plc - Overview
- STERIS plc - Business segments
- STERIS plc - Key news
- STERIS plc - Key offerings
- STERIS plc - Segment focus
- SWOT
- 15.15 Ted Pella Inc.
- Ted Pella Inc. - Overview
- Ted Pella Inc. - Product / Service
- Ted Pella Inc. - Key offerings
- SWOT
- 15.16 Towne Brothers Pvt. Ltd.
- Towne Brothers Pvt. Ltd. - Overview
- Towne Brothers Pvt. Ltd. - Product / Service
- Towne Brothers Pvt. Ltd. - Key offerings
- SWOT
- 15.17 World Precision Instruments
- World Precision Instruments - Overview
- World Precision Instruments - Product / Service
- World Precision Instruments - Key offerings
- SWOT
- 15.18 Ydm Corp.
- Ydm Corp. - Overview
- Ydm Corp. - Product / Service
- Ydm Corp. - Key offerings
- SWOT
16 Appendix
- 16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
